+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Nutrition For Cancer Care Market Size, Share & Trends Analysis Report by Product (Oral, Nutrition Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 125 Pages
  • March 2024
  • Region: Global
  • Grand View Research
  • ID: 5950115
Description Jump to:
The global clinical nutrition for cancer care market size is estimated to reach USD 7.95 billion by 2030, growing at a CAGR of 5.04% during the forecast period. Advancements in medical foods for cancer care have been a significant area of focus in research and development, aiming to enhance treatment outcomes and boost the overall quality of life for individuals battling cancer.

The growing statistics of patients with cancer underscore the increasing need for comprehensive strategies to address the nutritional burden and provide support for affected populations worldwide. Furthermore, weakened immunity due to cancer affects the response to the treatment as well as increases treatment-related toxicity. Hence, to maintain nutrition and positive nitrogen balance, various type of clinical nutrition such as tube feeding is used.

Many market players intend to tackle the byproducts of oncological treatment, namely malnutrition, cachexia, and diminished physical function, using effective nutritional strategies. Addressing these nutritional issues involves personalized interventions by healthcare providers, including nutritional counseling, dietary modifications, and potentially oral nutritional supplements.

Technological advancements in allied industries, such as enteral feeding devices, positively impact market growth. Key players are launching products that can be administered through the enteral route, propelling the market growth. Furthermore, government support in the form of approvals is anticipated to fuel the market growth over the forecast period.

Clinical Nutrition for Cancer Care Market Report Highlights

  • The significance of clinical nutrition for cancer patient care assures upwards growth for the market as it improves quality of life and treatment outcomes. With the growing emphasis on personalized treatments for various illnesses, including cancer and cystic fibrosis, the application of clinical nutrition has gained momentum.
  • The U.S. dominated the North America market with over 87% market revenue share, owing to its emphasis on research and substantial investment in the development of nutritional alternatives.
  • To cater to diverse nutritional needs, there has been a significant rise in the introduction of new oncology nutrition products, specifically designed to aid patients in combating diseases and managing the after-effects of treatment.
  • Oral nutrition led the product segment in 2023 with over 44% market share; however, parenteral feeding formulas are anticipated to register lucrative growth in the future.
  • Market growth is dominant for adult patients with cancer consuming medical foods. Moreover, the adults segment is expected to register the fastest CAGR from 2024 to 2030. This is attributable to the widespread occurrence of malnutrition in adult patients with cancer.
  • To cater to their nutritional needs, there has been a significant rise in the introduction of new oncology nutrition products, specifically designed to aid patients in combating diseases and managing the after-effects of treatment.
  • Clinical nutrition for cancer care market in Europe was the second-largest regional market in 2023, and Germany is estimated to dominate the market in the region over the forecast period.
  • To strengthen their positions in the clinical nutrition sector focused on cancer care, companies have undertaken strategic mergers and acquisitions to enrich their portfolios and boost market reach.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Stage
1.2.3. Sales Channel
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Stage Outlook
2.2.3. Sales Channel Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Clinical Nutrition for Cancer Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.3. Global Clinical Nutrition for Cancer Care Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Clinical Nutrition for Cancer Care Market: Product Estimates & Trend Analysis
4.1. Global Clinical Nutrition for Cancer Care Market: Product Dashboard
4.2. Global Clinical Nutrition for Cancer Care Market: Product Movement Analysis
4.3. Global Clinical Nutrition for Cancer Care Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4. Oral Nutrition
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Parenteral Nutrition
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Enteral Feeding Formulas
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Clinical Nutrition for Cancer Care Market: Stage Estimates & Trend Analysis
5.1. Clinical Nutrition for Cancer Care Market: Stage Dashboard
5.2. Clinical Nutrition for Cancer Care Market: Stage Movement Analysis
5.3. Clinical Nutrition for Cancer Care Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. Adult
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Pediatric
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Clinical Nutrition for Cancer Care Market: Sales Channel Estimates & Trend Analysis
6.1. Global Clinical Nutrition for Cancer Care Market: Sales Channel Dashboard
6.2. Global Clinical Nutrition for Cancer Care Market: Sales Channel Movement Analysis
6.3. Global Clinical Nutrition for Cancer Care Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4. Online
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Retail
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Institutional Sales
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Clinical Nutrition for Cancer Care Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Denmark
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Norway
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. China
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Japan
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. Thailand
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. South Korea
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Abbott Nutrition
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Pfizer Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Bayer AG
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Nestle Health Science S.A.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. GlaxoSmithKline plc
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Baxter International Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Otsuka Holdings Co., Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Mead Johnson & Company, LLC
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Danone Nutricia
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Victus, Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global clinical nutrition for cancer care market, 2018 - 2030 (USD Million)
Table 3 Global clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 4 Global clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 5 Global clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 6 North America clinical nutrition for cancer care market, by country, 2018 - 2030 (USD Million)
Table 7 North America clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 8 North America clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 9 North America clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 10 U.S. clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 11 U.S. clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 12 U.S. clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 13 Canada clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 14 Canada clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 15 Canada clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 16 Europe clinical nutrition for cancer care market, by country, 2018 - 2030 (USD Million)
Table 17 Europe clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 18 Europe clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 19 Europe clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 20 UK clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 21 UK clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 22 UK clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 23 Germany clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 24 Germany clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 25 Germany clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 26 France clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 27 France clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 28 France clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 29 Italy clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 30 Italy clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 31 Italy clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 32 Spain clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 33 Spain clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 34 Spain clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 35 Denmark clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 36 Denmark clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 37 Denmark clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 38 Sweden clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 39 Sweden clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 40 Sweden clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 41 Norway clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 42 Norway clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 43 Norway clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 44 Asia Pacific clinical nutrition for cancer care market, by country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 46 Asia Pacific clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 47 Asia Pacific clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 48 China clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 49 China clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 50 China clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 51 Japan clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 52 Japan clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 53 Japan clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 54 India clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 55 India clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 56 India clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 57 Australia clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 58 Australia clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 59 Australia clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 60 Thailand clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 61 Thailand clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 62 Thailand clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 63 South Korea clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 64 South Korea clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 65 South Korea clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 66 Latin America clinical nutrition for cancer care market, by country, 2018 - 2030 (USD Million)
Table 67 Latin America clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 68 Latin America clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 69 Latin America clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 70 Brazil clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 71 Brazil clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 72 Brazil clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 73 Mexico clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 74 Mexico clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 75 Mexico clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 76 Argentina clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 77 Argentina clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 78 Argentina clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 79 MEA clinical nutrition for cancer care market, by country, 2018 - 2030 (USD Million)
Table 80 MEA clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 81 MEA clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 82 MEA clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 83 South Africa clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 84 South Africa clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 85 South Africa clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 89 UAE clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 90 UAE clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 91 UAE clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
Table 92 Kuwait clinical nutrition for cancer care market, by product, 2018 - 2030 (USD Million)
Table 93 Kuwait clinical nutrition for cancer care market, by stage, 2018 - 2030 (USD Million)
Table 94 Kuwait clinical nutrition for cancer care market, by sales channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Clinical nutrition for cancer care market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Product and stage segment snapshot
Fig. 11 Sales channel segment snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 Clinical nutrition for cancer care market: Product outlook and key takeaways
Fig. 16 Clinical nutrition for cancer care market: Product movement analysis
Fig. 17 Oral nutrition market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Parenteral nutrition market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Enteral feeding formulas market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Clinical nutrition for cancer care market: Stage outlook and key takeaways
Fig. 21 Clinical nutrition for cancer care market: Stage movement analysis
Fig. 22 Adult market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Clinical nutrition for cancer care market: Sales channel outlook and key takeaways
Fig. 25 Clinical nutrition for cancer care market: Sales channel movement analysis
Fig. 26 Online market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Retail market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Institutional sales market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Clinical nutrition for cancer care market revenue, by region, 2023 & 2030 (USD Million)
Fig. 30 Regional marketplace: Key takeaways (1/2)
Fig. 31 Regional marketplace: Key takeaways (2/2)
Fig. 32 North America clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Key country dynamics
Fig. 34 U.S. clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Key country dynamics
Fig. 36 Canada clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 Europe clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Key country dynamics
Fig. 40 UK clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 Germany clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 France clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Italy clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 Spain clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Denmark clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Sweden clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Norway clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 Asia Pacific clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 China clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 Japan clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 India clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Australia clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Thailand clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 South Korea clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Latin America clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Brazil clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 Mexico clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 Argentina clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 MEA clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 South Africa clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Saudi Arabia clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 UAE clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Kuwait clinical nutrition for cancer care market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Company market share analysis, 2023
Fig. 89 Strategic framework

Companies Mentioned

  • Abbott Nutrition
  • Pfizer Inc.
  • Bayer AG
  • Nestle Health Science S.A.
  • GlaxoSmithKline plc
  • Baxter International Inc.
  • Otsuka Holdings Co., Ltd.
  • Mead Johnson & Company, LLC
  • Danone Nutricia
  • Victus, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages125
PublishedMarch 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 5.63 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.95 Billion
Compound Annual Growth Rate5.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Clinical Nutrition For Alzheimer's Disease Market Size, Share & Trends Analysis Report By Product (Oral, Enteral), By Stage (Adult, Pediatric), By Sales Channel (Online Sales Channels, Retail Sales Channel), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Nutrition For Alzheimer's Disease Market Size, Share & Trends Analysis Report By Product (Oral, Enteral), By Stage (Adult, Pediatric), By Sales Channel (Online Sales Channels, Retail Sales Channel), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 125 Pages
  • Global
From
Clinical Nutrition Market Size, Share & Trends Analysis Report by Product (Parenteral, Enteral, Oral), Application (Malabsorption/GI Disorder/Diarrhea, Cancer Care), Sales Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Clinical Nutrition Market Size, Share & Trends Analysis Report by Product (Parenteral, Enteral, Oral), Application (Malabsorption/GI Disorder/Diarrhea, Cancer Care), Sales Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Clinical Nutrition for Cancer Care Global Market Report 2024 - Product Image

Clinical Nutrition for Cancer Care Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Clinical Nutrition Market by Product, Consumer, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Clinical Nutrition Market by Product, Consumer, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Clinical Nutrition Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Clinical Nutrition Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From

About the Clinical Nutrition For Cancer Care Market

In the healthcare services sector, the Clinical Nutrition for Cancer Care market encompasses products and services dedicated to addressing the nutritional needs of cancer patients. Cancer care often necessitates specialized nutrition plans to help patients maintain their strength, manage treatment side effects, and improve their quality of & life. Malnutrition and weight loss are common in cancer patients, affecting treatment efficacy and survival rates. Therefore, clinical nutrition in cancer care includes enteral and parenteral nutrition, dietary supplements, and counseling from dietitians or nutritional specialists who develop personalized nutrition strategies. Clinical nutrition products range from high-calorie, protein-rich shakes to micronutrient supplements, and they are designed to meet the unique requirements of cancer patients undergoing chemotherapy, radiation, or surgery. Companies in this market are engaged in research and development of new formulations that align with the latest clinical guidelines and patient needs, and often collaborate with healthcare institutions to provide comprehensive nutritional care. Some companies and entities that operate within the Clinical Nutrition for Cancer Care market include Abbott Nutrition, Nestle Health Science, Danone Nutricia, Fresenius Kabi, and B. Braun. These organizations produce a range of nutritional products specifically tailored for oncology patients and are key players in advancing the field of nutritional support for cancer care. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.